159 related articles for article (PubMed ID: 29377152)
1. A presynaptic congenital myasthenic syndrome attributed to a homozygous sequence variant in LAMA5.
Maselli RA; Arredondo J; Vázquez J; Chong JX; Bamshad MJ; Nickerson DA; Lara M; Ng F; Lo VL; Pytel P; McDonald CM
Ann N Y Acad Sci; 2018 Feb; 1413(1):119-125. PubMed ID: 29377152
[TBL] [Abstract][Full Text] [Related]
2. Presynaptic congenital myasthenic syndrome with a homozygous sequence variant in LAMA5 combines myopia, facial tics, and failure of neuromuscular transmission.
Maselli RA; Arredondo J; Vázquez J; Chong JX; ; Bamshad MJ; Nickerson DA; Lara M; Ng F; Lo VL; Pytel P; McDonald CM
Am J Med Genet A; 2017 Aug; 173(8):2240-2245. PubMed ID: 28544784
[TBL] [Abstract][Full Text] [Related]
3. How to Spot Congenital Myasthenic Syndromes Resembling the Lambert-Eaton Myasthenic Syndrome? A Brief Review of Clinical, Electrophysiological, and Genetics Features.
Lorenzoni PJ; Scola RH; Kay CSK; Werneck LC; Horvath R; Lochmüller H
Neuromolecular Med; 2018 Jun; 20(2):205-214. PubMed ID: 29696584
[TBL] [Abstract][Full Text] [Related]
4. [Histochemical findings of and fine structural changes in motor endplates in diseases with neuromuscular transmission abnormalities].
Yoshimura T; Motomura M; Tsujihata M
Brain Nerve; 2011 Jul; 63(7):719-27. PubMed ID: 21747142
[TBL] [Abstract][Full Text] [Related]
5. Mutations in LAMB2 causing a severe form of synaptic congenital myasthenic syndrome.
Maselli RA; Ng JJ; Anderson JA; Cagney O; Arredondo J; Williams C; Wessel HB; Abdel-Hamid H; Wollmann RL
J Med Genet; 2009 Mar; 46(3):203-8. PubMed ID: 19251977
[TBL] [Abstract][Full Text] [Related]
6. Dominant and recessive congenital myasthenic syndromes caused by SYT2 mutations.
Maselli RA; Wei DT; Hodgson TS; Sampson JB; Vazquez J; Smith HL; Pytel P; Ferns M
Muscle Nerve; 2021 Aug; 64(2):219-224. PubMed ID: 34037996
[TBL] [Abstract][Full Text] [Related]
7. Recessive congenital myasthenic syndrome caused by a homozygous mutation in SYT2 altering a highly conserved C-terminal amino acid sequence.
Maselli RA; van der Linden H; Ferns M
Am J Med Genet A; 2020 Jul; 182(7):1744-1749. PubMed ID: 32250532
[TBL] [Abstract][Full Text] [Related]
8. Monozygous twins with neuromuscular transmission defects at opposite sides of the motor endplate.
Punga AR; Nygren I; Askmark H; Stålberg EV
Acta Neurol Scand; 2009 Mar; 119(3):207-11. PubMed ID: 18684214
[TBL] [Abstract][Full Text] [Related]
9. The role of laminins in the organization and function of neuromuscular junctions.
Rogers RS; Nishimune H
Matrix Biol; 2017 Jan; 57-58():86-105. PubMed ID: 27614294
[TBL] [Abstract][Full Text] [Related]
10. Novel congenital myasthenic syndromes associated with defects in quantal release.
Milone M; Fukuda T; Shen XM; Tsujino A; Brengman J; Engel AG
Neurology; 2006 Apr; 66(8):1223-9. PubMed ID: 16525123
[TBL] [Abstract][Full Text] [Related]
11. Secondary changes of the motor endplate in Lambert-Eaton myasthenic syndrome: a quantitative study.
Hesselmans LF; Jennekens FG; Kartman J; Wokke JH; de Visser M; Klaver-Krol EG; DeBaets M; Spaans F; Veldman H
Acta Neuropathol; 1992; 83(2):202-6. PubMed ID: 1557950
[TBL] [Abstract][Full Text] [Related]
12. Novel delta subunit mutation in slow-channel syndrome causes severe weakness by novel mechanisms.
Gomez CM; Maselli RA; Vohra BP; Navedo M; Stiles JR; Charnet P; Schott K; Rojas L; Keesey J; Verity A; Wollmann RW; Lasalde-Dominicci J
Ann Neurol; 2002 Jan; 51(1):102-12. PubMed ID: 11782989
[TBL] [Abstract][Full Text] [Related]
13. Electrophysiological evaluation of the neuromuscular junction: a brief review.
Kouyoumdjian JA; Estephan EP
Arq Neuropsiquiatr; 2023 Dec; 81(12):1040-1052. PubMed ID: 38157872
[TBL] [Abstract][Full Text] [Related]
14. Immature end-plates and utrophin deficiency in congenital myasthenic syndrome caused by epsilon-AChR subunit truncating mutations.
Sieb JP; Kraner S; Rauch M; Steinlein OK
Hum Genet; 2000 Aug; 107(2):160-4. PubMed ID: 11030414
[TBL] [Abstract][Full Text] [Related]
15. Treatment for Lambert-Eaton myasthenic syndrome.
Maddison P; Newsom-Davis J
Cochrane Database Syst Rev; 2003; (2):CD003279. PubMed ID: 12804456
[TBL] [Abstract][Full Text] [Related]
16. Tubular aggregates in autoimmune Lambert-Eaton myasthenic syndrome.
Cordts I; Funk F; Schulz JB; Weis J; Claeys KG
Neuromuscul Disord; 2016 Dec; 26(12):880-884. PubMed ID: 27816328
[TBL] [Abstract][Full Text] [Related]
17. Presynaptic Disorders: Lambert-Eaton Myasthenic Syndrome and Botulism.
Gable KL; Massey JM
Semin Neurol; 2015 Aug; 35(4):340-6. PubMed ID: 26502758
[TBL] [Abstract][Full Text] [Related]
18. Synaptotagmin 2 mutations cause an autosomal-dominant form of lambert-eaton myasthenic syndrome and nonprogressive motor neuropathy.
Herrmann DN; Horvath R; Sowden JE; Gonzalez M; Sanchez-Mejias A; Guan Z; Whittaker RG; Almodovar JL; Lane M; Bansagi B; Pyle A; Boczonadi V; Lochmüller H; Griffin H; Chinnery PF; Lloyd TE; Littleton JT; Zuchner S
Am J Hum Genet; 2014 Sep; 95(3):332-9. PubMed ID: 25192047
[TBL] [Abstract][Full Text] [Related]
19. Motor endplate remodeling in some cases with congenital myasthenic syndrome.
Fidziańska A; Glinka Z
Folia Neuropathol; 2010; 48(3):200-5. PubMed ID: 20925004
[TBL] [Abstract][Full Text] [Related]
20. Presynaptic congenital myasthenic syndrome with altered synaptic vesicle homeostasis linked to compound heterozygous sequence variants in RPH3A.
Maselli RA; Vázquez J; Schrumpf L; Arredondo J; Lara M; Strober JB; Pytel P; Wollmann RL; Ferns M
Mol Genet Genomic Med; 2018 May; 6(3):434-440. PubMed ID: 29441694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]